Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Estibaliz Capetillo-Zarate

Showing results (31-40 of 46) with videos related to

Pageof 5
Sort By:
Journal of Inflammation Research|December 1, 2021
Whole Blood Expression Pattern of Inflammation and Redox Genes in Mild Alzheimer's DiseaseElena Milanesi, Maria Dobre, Cătălina Anca Cucos, et al.
International Journal of Molecular Sciences|August 26, 2022
New, Fully Implantable Device for Selective Clearance of CSF-Target Molecules: Proof of Concept in a Murine Model of Alzheimer's DiseaseMaría Almudena Coto-Vilcapoma, Juan Castilla-Silgado, Benjamín Fernández-García, et al.
International Journal of Molecular Sciences|May 11, 2024
Assessment of the Correlation and Diagnostic Accuracy between Cerebrospinal Fluid and Plasma Alzheimer's Disease Biomarkers: A Comparison of the Lumipulse and Simoa PlatformsFarida Dakterzada, Raffaela Cipriani, Ricard López-Ortega, et al.
Acta Neuropathologica|October 1, 2005
Apolipoprotein E co-localizes with newly formed amyloid beta-protein (Abeta) deposits lacking immunoreactivity against N-terminal epitopes of Abeta in a genotype-dependent mannerDietmar Rudolf Thal, Estibaliz Capetillo-Zarate, Christian Schultz, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|August 7, 2009
Synaptic activity reduces intraneuronal Abeta, promotes APP transport to synapses, and protects against Abeta-related synaptic alterationsDavide Tampellini, Nawreen Rahman, Eduardo F Gallo, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|January 27, 2012
Transgenic expression of intraneuronal Aβ42 but not Aβ40 leads to cellular Aβ lesions, degeneration, and functional impairment without typical Alzheimer's disease pathologyDorothee Abramowski, Sabine Rabe, Ajeet Rijal Upadhaya, et al.
Scientific Reports|August 27, 2025
Stepwise approach to alzheimer's disease diagnosis in primary care using cognitive screening, risk factors, neuroimaging and plasma biomarkersMiren Altuna, Maite García-Sebastián, Raffaela Cipriani, et al.
Alzheimer'S Research & Therapy|June 8, 2022
Longitudinal evaluation of neuroinflammation and oxidative stress in a mouse model of Alzheimer disease using positron emission tomographyLuka Rejc, Vanessa Gómez-Vallejo, Ana Joya, et al.
EMBO Molecular Medicine|July 6, 2018
P2X4 receptor controls microglia activation and favors remyelination in autoimmune encephalitisAlazne Zabala, Nuria Vazquez-Villoldo, Björn Rissiek, et al.
Parkinsonism & Related Disorders|February 12, 2022
Characterization of molecular biomarkers in cerebrospinal fluid and serum of E46K-SNCA mutation carriersAne Murueta-Goyena, Raffaela Cipriani, Mar Carmona-Abellán, et al.
Pageof 5

Showing results (31-40 of 46) with videos related to

Sort By:
Pageof 5
Journal of Inflammation Research|December 1, 2021
Whole Blood Expression Pattern of Inflammation and Redox Genes in Mild Alzheimer's DiseaseElena Milanesi, Maria Dobre, Cătălina Anca Cucos, et al.
International Journal of Molecular Sciences|August 26, 2022
New, Fully Implantable Device for Selective Clearance of CSF-Target Molecules: Proof of Concept in a Murine Model of Alzheimer's DiseaseMaría Almudena Coto-Vilcapoma, Juan Castilla-Silgado, Benjamín Fernández-García, et al.
International Journal of Molecular Sciences|May 11, 2024
Assessment of the Correlation and Diagnostic Accuracy between Cerebrospinal Fluid and Plasma Alzheimer's Disease Biomarkers: A Comparison of the Lumipulse and Simoa PlatformsFarida Dakterzada, Raffaela Cipriani, Ricard López-Ortega, et al.
Acta Neuropathologica|October 1, 2005
Apolipoprotein E co-localizes with newly formed amyloid beta-protein (Abeta) deposits lacking immunoreactivity against N-terminal epitopes of Abeta in a genotype-dependent mannerDietmar Rudolf Thal, Estibaliz Capetillo-Zarate, Christian Schultz, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|August 7, 2009
Synaptic activity reduces intraneuronal Abeta, promotes APP transport to synapses, and protects against Abeta-related synaptic alterationsDavide Tampellini, Nawreen Rahman, Eduardo F Gallo, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|January 27, 2012
Transgenic expression of intraneuronal Aβ42 but not Aβ40 leads to cellular Aβ lesions, degeneration, and functional impairment without typical Alzheimer's disease pathologyDorothee Abramowski, Sabine Rabe, Ajeet Rijal Upadhaya, et al.
Scientific Reports|August 27, 2025
Stepwise approach to alzheimer's disease diagnosis in primary care using cognitive screening, risk factors, neuroimaging and plasma biomarkersMiren Altuna, Maite García-Sebastián, Raffaela Cipriani, et al.
Alzheimer'S Research & Therapy|June 8, 2022
Longitudinal evaluation of neuroinflammation and oxidative stress in a mouse model of Alzheimer disease using positron emission tomographyLuka Rejc, Vanessa Gómez-Vallejo, Ana Joya, et al.
EMBO Molecular Medicine|July 6, 2018
P2X4 receptor controls microglia activation and favors remyelination in autoimmune encephalitisAlazne Zabala, Nuria Vazquez-Villoldo, Björn Rissiek, et al.
Parkinsonism & Related Disorders|February 12, 2022
Characterization of molecular biomarkers in cerebrospinal fluid and serum of E46K-SNCA mutation carriersAne Murueta-Goyena, Raffaela Cipriani, Mar Carmona-Abellán, et al.
Pageof 5